[MDGL] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
11-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -7.32%
YoY- -33.32%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 0 0 0 0 7,437 3,423 4,037 -
PBT -7,749 -10,536 -20,352 -24,162 -47,380 -47,380 -37,467 -23.08%
Tax 142 0 0 0 -44,667 -36,637 -28,644 -
NP -7,749 -10,536 -20,352 -24,162 -18,123 -10,743 -8,823 -2.13%
Tax Rate - - - - - - - -
Total Cost 7,749 10,536 20,352 24,162 25,560 14,166 12,860 -8.08%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 0.00 0.00 0.00 0.00 -243.69 -313.85 -218.55 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.67 -2.68 -6.57 -9.90 -9.19 -6.67 -7.48 -33.08%
EPS Diluted -0.67 -2.68 -6.57 -9.90 -9.19 -6.67 -7.35 -32.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.